Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms
    Published on 2023-07-24
    3 years ago
  • Therapeutic mechanisms of psychedelics and entactogens
    Published on 2023-07-24
    3 years ago
  • Increasing ecological validity in neuropsychopharmacology research on the relationship between alcohol use and uncertain stressors
    Published on 2023-07-24
    3 years ago
  • Disassociating drug active ingredients from inactive: ketamine-like synaptic effects of a ketamine excipient
    Published on 2023-07-24
    3 years ago
  • Herpesviruses and neuropsychiatric disorders: overlooked adversaries or innocent bystanders?
    Published on 2023-07-21
    3 years ago
  • Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism
    Published on 2023-07-21
    3 years ago
  • Neurobiology and treatment advances for prolonged grief disorder
    Published on 2023-07-21
    3 years ago
« Previous 1 … 127 128 129 130 131 … 143 Next »
Journal of Psychopharmacology
  • Designer benzodiazepines’ pharmacological effects and potencies: How to find the information
    Published on 2020-01-23
    7 years ago
  • The generalizability of clinical and experimental tobacco research: Do exclusion criteria impact men and women differently?
    Published on 2020-01-22
    7 years ago
  • Chronic social defeat stress: Impacts on ethanol-induced stimulation, corticosterone response, and brain monoamine levels
    Published on 2020-01-22
    7 years ago
  • Plasma monoamines change under dopamine supersensitivity psychosis in patients with schizophrenia: A comparison with first-episode psychosis
    Published on 2020-01-21
    7 years ago
  • Lights and shadows of schizophrenia therapy research: Lessons from oral risperidone and olanzapine
    Published on 2020-01-21
    7 years ago
  • Decreased nuclear distribution nudE-like 1 enzyme activity in an animal model with dysfunctional disrupted-in-schizophrenia 1 signaling featuring aberrant neurodevelopment and amphetamine-supersensitivity
    Published on 2020-01-09
    7 years ago
  • Cannabinoid receptor type 1 in the bed nucleus of the stria terminalis modulates cardiovascular responses to stress via local N-methyl-D-aspartate receptor/neuronal nitric oxide synthase/soluble guanylate cyclase/protein kinase G signaling
    Published on 2020-01-08
    7 years ago
« Previous 1 … 127 128 129 130 131 … 154 Next »
European Neuropsychopharmacology
  • Increased thin-spine density in frontal cortex pyramidal neurons in a genetic rat model of schizophrenia-relevant features
    Published on 2021-01-22
    6 years ago
  • Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers
    Published on 2021-01-22
    6 years ago
  • Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis
    Published on 2021-01-20
    6 years ago
  • Maternal ADHD medication use during pregnancy and the risk of ADHD in children: Importance of genetic predispositions and impact of using a sibling analysis
    Published on 2021-01-16
    6 years ago
  • Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study
    Published on 2021-01-15
    6 years ago
  • Maternal crack cocaine use in rats leads to depressive- and anxiety-like behavior, memory impairment, and increased seizure susceptibility in the offspring
    Published on 2021-01-14
    6 years ago
  • Primary role for melatonin MT2 receptors in the regulation of anhedonia and circadian temperature rhythm
    Published on 2021-01-13
    6 years ago
« Previous 1 … 127 128 129 130 131 … 170 Next »

   Pharma Pub